BGLC BioNexus Gene Lab Corp - Common stock
$1,57
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 14, 2026
Rango 52S
$1–$6
10% of range
Calificación del Analista
—
Precio Objetivo
—
P/E (TTM)
-1.0
ROE
-37.0%
Margen de Beneficio Neto
-40.2%
BGLC Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$1.57
Capitalización Bursátil
$4M
P/E (TTM)
-1.0
BPA (TTM)
$-0.09
Ingresos (TTM)
$7M
Rendimiento div.
—
ROE
-37.0%
Deuda/Capital
—
Rango 52S
$1 – $6
BGLC Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$7M
2018-12-31
→
2025-12-31
BPA
$-0.09
2023-12-31
→
2024-12-31
Flujo de caja libre
$-2M
2019-12-31
→
2025-12-31
Márgenes
-40.2%
2019-12-31
→
2025-12-31
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
BGLC
Mediana de Pares
P/E (TTM)
-1.0
12.4
P/S (TTM) (P/V (TTM))
0.5
0.5
P/B (P/C)
0.4
1.1
Price / FCF (Precio / FCF)
-2.0
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
BGLC
Mediana de Pares
Gross Margin (Margen Bruto)
14.6%
26.1%
Operating Margin (Margen Operativo)
-39.9%
—
Net Profit Margin (Margen de Beneficio Neto)
-40.2%
-2.7%
ROA
-30.3%
-5.6%
ROE
-37.0%
-20.3%
ROIC
-34.4%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
BGLC
Mediana de Pares
Current Ratio (Ratio corriente)
10.5
1.3
Quick Ratio (Ratio Rápido)
5.7
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
BGLC
Mediana de Pares
Revenue YoY (Ingresos interanuales)
-21.9%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
-12.1%
—
Revenue CAGR 5Y (Ingresos CAGR 5A)
-8.2%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
BGLC
Mediana de Pares
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 15
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7M | $10M | $10M | $11M | $13M | $11M | $127.0K | $212.3K | |
| Cost of Revenue | $6M | $8M | $8M | $10M | $11M | $10M | $71.1K | $-183.6K | |
| Gross Profit | $1M | $1M | $1M | $1M | $2M | $2M | $55.9K | $28.8K | |
| R&D Expense | $50.7K | $47.5K | $55.0K | · | · | · | · | · | |
| SG&A Expense | $2M | $2M | $2M | $2M | $1M | $1M | $356.6K | $-241.9K | |
| Operating Expenses | $4M | $5M | $-4M | · | · | · | · | · | |
| Operating Income | $-3M | $-2M | $-3M | $-291.2K | $1M | $1M | $-275.7K | $59.9K | |
| Interest Expense | · | · | $13.9K | $12.5K | · | · | · | · | |
| Other Non-op | $432.1K | $2M | $486.0K | · | · | · | $29.2K | $-33.4K | |
| Pretax Income | $-3M | $-2M | $-3M | $-303.7K | $1M | · | · | · | |
| Income Tax | $0 | $-3.5K | $-21.5K | $-52.3K | $-291.3K | · | $24.8K | $-33.4K | |
| Net Income | $-3M | $-2M | $-3M | $-356.0K | $751.6K | $1M | $-246.5K | $26.5K | |
| EPS (Diluted) | · | $-0.09 | $-0.17 | · | · | · | · | · | |
| Shares (Diluted) | · | 17,818,483 | 15,875,455 | · | · | · | · | · | |
| EBITDA | $-3M | · | · | · | $1M | $1M | $-275.7K | · |
Balance general 22
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $3M | $3M | $611.8K | $578.5K | $3M | $859.1K | $1M | |
| Receivables | $505.9K | $1M | · | · | · | · | · | · | |
| Inventory | $676.7K | $1M | $1M | $977.8K | $2M | $1M | $7.6K | $15.3K | |
| Other Current Assets | $83.3K | $0 | · | · | · | · | · | · | |
| Current Assets | $5M | $7M | $8M | $6M | $7M | $8M | $882.6K | $1M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $312.9K | $341.8K | |
| PP&E (Gross) | $3M | $3M | $2M | $2M | $2M | · | $405.0K | $395.5K | |
| Accum. Depreciation | $868.8K | $757.0K | $659.1K | $616.9K | $525.6K | · | $98.2K | $56.5K | |
| Total Assets | $9M | $10M | $11M | $9M | $10M | $10M | $1M | $2M | |
| Accounts Payable | · | $2M | $1M | $2M | $2M | · | · | · | |
| Accrued Liabilities | $126.0K | $168.8K | · | · | · | · | · | · | |
| Current Liabilities | $521.0K | $2M | $2M | $2M | $2M | $3M | $51.6K | $62.9K | |
| Capital Leases | $116.9K | $159.7K | $98.8K | $40.2K | $24.6K | $42.4K | $12.2K | · | |
| Deferred Tax | · | $0 | $12.3K | $30.9K | $28.4K | · | · | · | |
| Total Liabilities | $637.9K | $2M | $2M | $2M | $2M | $3M | $108.9K | $130.3K | |
| Common Stock | $20M | $17M | $17M | $11M | $11M | $11M | $6M | $7M | |
| Paid-in Capital | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | |
| Retained Earnings | $-6M | $-3M | $-2M | $1M | $2M | $760.8K | $-333.3K | $-86.8K | |
| AOCI | $-120.7K | $-555.0K | $-677.3K | $-409.1K | $-100.3K | $133.7K | $-17.1K | $-27.0K | |
| Stockholders' Equity | $9M | $8M | $10M | $7M | $7M | $7M | $1M | $2M | |
| Liabilities + Equity | $9M | $10M | $11M | $9M | $10M | $10M | $1M | $2M | |
| Shares Outstanding | 2,417,314 | 1,796,766 | 17,667,663 | 14,476,513 | 171,218,152 | 171,218,152 | 102,730,891 | 74,627,558 |
Flujo de Efectivo 12
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $41.7K | $40.6K | |
| Stock-based Comp | $794.8K | $141.0K | · | · | · | · | · | · | |
| Deferred Tax | $0 | $12.3K | $17.4K | $-3.9K | $-26.7K | $1.2K | $4.5K | · | |
| Operating Cash Flow | $-2M | $-2M | $-2M | $551.8K | $9.2K | $552.7K | $-217.3K | $-274.1K | |
| CapEx | $37.0K | $227.0K | $149.4K | $0 | $3.2K | $421.6K | $12.8K | $-39.6K | |
| Investing Cash Flow | $944.8K | $418.2K | $-2M | $-450.5K | $-490.6K | $1M | $-12.8K | $-51.7K | |
| Stock Issued | · | · | · | · | · | · | $-163.0K | $741.5K | |
| Net Stock Activity | · | · | · | · | · | · | $-163.0K | · | |
| Financing Cash Flow | $298.8K | $4.0K | $6M | $108.2K | $-28.2K | $-4.9K | $-180.8K | $742.9K | |
| Net Change in Cash | $-400.6K | $-2M | $2M | $-5.1K | $-663.8K | · | · | · | |
| Taxes Paid | $-14.8K | $-40.4K | $-67.0K | $-170.4K | $-226.8K | $-143.5K | $-10.7K | · | |
| Free Cash Flow | $-2M | · | · | · | $6.0K | $131.1K | $-204.5K | · |
Rentabilidad 8
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 14.6% | · | · | · | 16.4% | 15.1% | 44.0% | · | |
| Operating Margin | -39.9% | · | · | · | 7.9% | 11.2% | -217.2% | · | |
| Net Margin | -40.2% | · | · | · | 5.6% | 9.6% | -194.1% | · | |
| Pretax Margin | -40.2% | · | · | · | · | · | · | · | |
| EBITDA Margin | -39.9% | · | · | · | 7.9% | 11.2% | -217.2% | · | |
| ROA | -30.3% | · | · | · | 7.6% | 19.3% | -17.1% | · | |
| ROE | -37.0% | · | · | · | 10.6% | 16.4% | -19.6% | · | |
| ROIC | -34.4% | · | · | · | · | · | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.5 | · | · | · | 3.1 | 2.4 | 17.1 | · | |
| Quick Ratio | 5.7 | · | · | · | 0.9 | 0.8 | 7.1 | · |
Eficiencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | · | · | · | 1.4 | 2.0 | 0.1 | · | |
| Inventory Turnover | 6.1 | · | · | · | 8.3 | 16.3 | -6.2 | · | |
| Receivables Turnover | 7.9 | · | · | · | · | · | · | · |
Tasas de Crecimiento 4
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -21.9% | -2.7% | -10.6% | -18.2% | 17.3% | · | · | · | |
| Revenue CAGR 3Y | -12.1% | -10.7% | -5.0% | · | · | · | · | · | |
| Revenue CAGR 5Y | -8.2% | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | · | -31.3% | · | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $10M | $10M | $11M | $13M | $11M | $127.0K | · | |
| Net Income TTM | $-3M | $-2M | $-3M | $-356.0K | $751.6K | $1M | $-246.5K | · | |
| Market Cap | $10M | · | · | · | $43.76B | · | · | · | |
| P/E | -2.6 | -31.1 | -31.9 | · | · | · | · | · | |
| P/S | 1.3 | · | · | · | 3275.1 | · | · | · | |
| P/B | 1.1 | · | · | · | 6095.4 | · | · | · | |
| P / Tangible Book | 1.1 | 6.0 | 9.7 | 2971.3 | 6095.4 | · | · | · | |
| P / Cash Flow | -5.2 | · | · | · | 4777137.8 | · | · | · | |
| P / FCF | -5.1 | · | · | · | 7295109.1 | · | · | · | |
| Earnings Yield | -38.5% | -3.2% | -3.1% | · | · | · | · | · |
Estado de resultados 15
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $76.2K | $22.8K | $483.8K | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $3M | $3M | $2M | $3M | $3M | |
| Cost of Revenue | $63.2K | $23.6K | $487.7K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | |
| Gross Profit | $13.0K | $-790 | $-4.0K | $377.7K | $368.0K | $343.5K | $309.2K | $326.5K | $288.7K | $365.0K | $266.6K | $354.3K | $339.7K | $368.9K | $339.2K | $299.5K | |
| R&D Expense | $13.7K | $14.5K | $11.1K | $14.9K | $12.6K | $12.1K | $17.4K | $10.4K | $8.2K | $11.5K | · | · | · | · | · | · | |
| SG&A Expense | $298.5K | $327.7K | $181.1K | $445.7K | $516.8K | $391.9K | $165.9K | $792.4K | $558.8K | $315.8K | $-2M | $3M | $807.1K | $536.9K | $487.8K | $418.8K | |
| Operating Expenses | $416.4K | $597.4K | $3M | $1M | $1M | $1M | $3M | $2M | $759.7K | $-645.9K | · | · | · | · | · | · | |
| Operating Income | $-282.4K | $-540.5K | $-1M | $-702.5K | $-611.3K | $-618.4K | $-416.2K | $-1M | $259.2K | $-79.0K | $257.8K | $-3M | $-272.2K | $-50.6K | $-122.7K | $-65.2K | |
| Interest Expense | · | · | · | · | · | · | · | $6.2K | $4.5K | $4.7K | · | $4.3K | $3.0K | $2.4K | $4.8K | $2.1K | |
| Other Non-op | · | $57.7K | $23.5K | $107.8K | $209.5K | $91.4K | $675.0K | $465.5K | $730.1K | $201.8K | · | · | · | · | · | · | |
| Pretax Income | $-286.5K | $-543.6K | $-1M | $-709.0K | $-616.2K | $-623.3K | $-422.0K | $-1M | $254.7K | $-83.7K | $253.6K | $-3M | $-275.2K | $-53.1K | $-127.5K | $-67.3K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $-40.6K | $1.6K | $55.6K | $-20.1K | $-97.9K | $76.4K | $16.0K | $-16.0K | $-75.1K | $10.1K | |
| Net Income | $-286.5K | $-543.6K | $-1M | $-709.0K | $-616.2K | $-623.3K | $-348.3K | $-1M | $199.1K | $-103.8K | $308.5K | $-3M | $-259.3K | $-69.1K | $-157.0K | $-77.4K | |
| EPS (Diluted) | $-0.12 | $-0.23 | · | $-0.40 | $-0.34 | $-0.35 | · | $-0.75 | $0.11 | $-0.01 | · | · | · | · | · | · | |
| Shares (Diluted) | 2,417,314 | 2,417,314 | · | 1,796,597 | 1,796,597 | 1,796,766 | · | 1,796,766 | 1,766,766 | 17,667,663 | · | · | · | · | · | · | |
| EBITDA | $-282.4K | $-540.5K | · | $-702.5K | $-611.3K | $-618.4K | · | $-1M | $259.2K | $-79.0K | · | · | · | · | · | $-65.2K |
Balance general 22
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1M | · | $2M | · | · | · | $3M | · | · | $2M | · | $5M | $297.1K | $406.8K | $611.8K | $478.2K | |
| Receivables | $15.5K | $79.9K | $505.9K | $2M | $2M | · | $1M | · | · | · | · | · | · | · | · | · | |
| Inventory | $652.9K | $667.2K | $676.7K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $899.6K | $977.8K | $1M | |
| Other Current Assets | $583.3K | $333.3K | $83.3K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Current Assets | $5M | $5M | $5M | $6M | $6M | $7M | $7M | $7M | $8M | $8M | $8M | $8M | $5M | $5M | $6M | $5M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | $1M | $1M | $2M | $1M | |
| PP&E (Gross) | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | |
| Accum. Depreciation | $925.2K | $897.1K | $868.8K | $840.4K | $811.4K | $783.6K | $757.0K | $729.2K | $695.0K | $679.3K | $659.1K | $638.4K | $616.0K | $611.2K | $616.9K | $592.2K | |
| Total Assets | $9M | $9M | $9M | $8M | $9M | $9M | $10M | $11M | $11M | $11M | $11M | $11M | $8M | $8M | $9M | $8M | |
| Accounts Payable | · | · | · | · | · | $1M | · | $1M | $954.8K | $1M | $1M | $2M | $2M | $1M | $2M | $1M | |
| Accrued Liabilities | $70.5K | $108.6K | $126.0K | · | · | · | $168.8K | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $812.9K | $796.5K | $521.0K | $678.0K | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | |
| Capital Leases | $89.3K | $103.8K | $116.9K | $126.9K | $141.3K | $147.9K | $159.7K | $178.4K | $182.7K | $88.8K | $98.8K | $104.9K | $29.7K | $35.7K | $40.2K | $14.1K | |
| Deferred Tax | · | · | · | $0 | $0 | $0 | · | $13.6K | $11.9K | $11.9K | $12.3K | $28.9K | $29.0K | $30.7K | $30.9K | $25.5K | |
| Total Liabilities | $948.0K | $946.9K | $637.9K | $805.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | |
| Common Stock | $20M | $20M | $20M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $11M | $11M | $11M | $11M | |
| Paid-in Capital | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | |
| Retained Earnings | $-7M | $-7M | $-6M | $-5M | $-5M | $-4M | $-3M | $-3M | $-2M | $-2M | $-2M | $-2M | $828.1K | $1M | $1M | $1M | |
| AOCI | $-127.2K | $-98.8K | $-120.7K | $-112.5K | $-115.8K | $-482.8K | $-555.0K | $-162.1K | $-884.7K | $-887.2K | $-677.3K | $-800.6K | $-782.0K | $-448.1K | $-409.1K | $-807.4K | |
| Stockholders' Equity | $8M | $8M | $9M | $7M | $8M | $8M | $8M | $9M | $10M | $9M | $10M | $10M | $6M | $7M | $7M | $6M | |
| Liabilities + Equity | $9M | $9M | $9M | $8M | $9M | $9M | $10M | $11M | $11M | $11M | $11M | $11M | $8M | $8M | $9M | $8M | |
| Shares Outstanding | 2,417,314 | 2,417,314 | 2,417,314 | 1,796,597 | 1,796,597 | 17,967,663 | 1,796,766 | 17,967,663 | 17,667,663 | 17,667,663 | 17,667,663 | 17,792,663 | 173,718,152 | 173,718,152 | 14,476,513 | 173,718,152 |
Flujo de Efectivo 9
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | · | · | $794.8K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | $16.0K | · | · | · | |
| Operating Cash Flow | $-422.5K | $-147.7K | $961.1K | $-1M | $-737.9K | $-824.1K | $219.2K | $-2M | $-675.0K | $-37.2K | $-782.5K | $-899.3K | $-22.0K | $-116.5K | $476.7K | $312.7K | |
| CapEx | $250 | $325 | $977 | $5.5K | $21.5K | $9.1K | $4.0K | $199.2K | $1.8K | $21.9K | $937 | $134.0K | $14.4K | $102 | $-37.1K | $3.7K | |
| Investing Cash Flow | $416.1K | $-14.0K | $-5.7K | $994.6K | $-28.5K | $-15.6K | $554.4K | $-243.4K | $42.9K | $3.6K | $-1M | $-360.7K | $-3.1K | $-5.1K | $-49.9K | $18.4K | |
| Financing Cash Flow | $13.6K | $59.7K | $266.5K | $34.2K | $-1.0K | $-860 | $-142.4K | $-51.4K | $178.1K | $26.9K | $531.7K | $6M | $-2.4K | $-1.8K | $-2.3K | $-5.5K | |
| Net Change in Cash | $-6.0K | $-88.4K | $1M | $-180.1K | $-552.2K | $-797.5K | $221.6K | $-1M | $-458.3K | $-79.0K | $-2M | $4M | $-214.5K | $-145.7K | $-666.7K | $1M | |
| Taxes Paid | $0 | $0 | $-154 | $-2.2K | $-7.6K | $-4.9K | $-538 | $-13.1K | $-12.3K | $-14.5K | $-19.2K | $-17.2K | $-18.2K | $-12.4K | $-294.0K | $50.1K | |
| Free Cash Flow | · | $-148.0K | · | · | · | $-833.1K | · | · | · | · | · | · | · | · | · | · |
Rentabilidad 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 17.1% | -3.5% | · | 14.8% | 16.3% | 16.1% | · | 12.4% | 14.6% | 15.3% | · | · | · | · | · | 11.6% | |
| Operating Margin | -370.8% | -2366.2% | · | -27.6% | -27.1% | -28.9% | · | -50.8% | 13.1% | -3.3% | · | · | · | · | · | -2.5% | |
| Net Margin | -376.1% | -2379.7% | · | -27.9% | -27.3% | -29.2% | · | -51.1% | 10.1% | -4.4% | · | · | · | · | · | -3.0% | |
| Pretax Margin | -376.1% | -2379.7% | · | -27.9% | -27.3% | -29.2% | · | -51.1% | 12.9% | -3.5% | · | · | · | · | · | -2.6% | |
| EBITDA Margin | -370.8% | -2366.2% | · | -27.6% | -27.1% | -28.9% | · | -50.8% | 13.1% | -3.3% | · | · | · | · | · | -2.5% | |
| ROA | -3.2% | -5.9% | · | -7.6% | -6.0% | -6.0% | · | -12.0% | 2.1% | -1.1% | · | · | · | · | · | -0.88% | |
| ROE | -3.7% | -6.9% | · | -8.8% | -7.2% | -7.3% | · | -14.1% | 2.6% | -1.3% | · | · | · | · | · | -1.1% | |
| ROIC | -3.6% | -6.7% | · | -10.3% | -8.1% | -8.0% | · | -14.3% | 3.3% | -0.64% | · | · | · | · | · | -1.2% |
Liquidez y Solvencia 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | 6.5 | · | 8.3 | 3.6 | 4.2 | · | 5.0 | 5.6 | 4.6 | · | · | · | · | · | 4.1 | |
| Quick Ratio | 1.5 | 0.1 | · | 2.2 | 1.1 | · | · | · | · | 1.5 | · | · | · | · | · | 0.4 | |
| Interest Coverage | · | · | · | · | · | · | · | -216.0 | · | -17.0 | · | · | · | · | · | · |
Eficiencia 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.3 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | · | · | · | · | 0.3 | |
| Inventory Turnover | 0.1 | 0.0 | · | 1.8 | 1.7 | 1.6 | · | 1.8 | 1.5 | 2.0 | · | · | · | · | · | 1.8 | |
| Receivables Turnover | 0.1 | 0.6 | · | 3.3 | 2.4 | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5M | $7M | · | $10M | $9M | $9M | · | $10M | $9M | $10M | · | $10M | $10M | $10M | · | $12M | |
| Net Income TTM | $-2M | $-2M | · | $-3M | $-2M | $-2M | · | $-4M | $-3M | $-3M | · | $-3M | $-544.4K | $-268.1K | · | $96.3K | |
| Market Cap | $5M | $5M | · | $10M | $6M | $42M | · | $80M | $84M | $125M | · | · | · | · | · | $22.10B | |
| P/E | -1.8 | -1.6 | · | -3.6 | -3.0 | -3.5 | · | · | · | · | · | · | · | · | · | · | |
| P/S | 1.0 | 0.7 | · | 1.0 | 0.6 | 4.6 | · | 8.4 | 8.9 | 12.6 | · | · | · | · | · | 1894.3 | |
| P/B | 0.6 | 0.6 | · | 1.4 | 0.7 | 5.5 | · | 8.5 | 8.8 | 13.3 | · | · | · | · | · | 3439.9 | |
| P / Tangible Book | 0.6 | 0.6 | · | 1.4 | 0.7 | 5.5 | · | 8.5 | 8.8 | 13.3 | · | 16.0 | 772.5 | 1716.8 | · | 3439.9 | |
| P / Cash Flow | · | -35.0 | · | · | · | -51.5 | · | · | · | -3621.6 | · | · | · | · | · | · | |
| P / FCF | · | -35.0 | · | · | · | -50.9 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -55.4% | -61.2% | · | -27.8% | -33.0% | -28.7% | · | · | · | · | · | · | · | · | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $7M | $10M | $10M | $11M | $13M |
| Margen Bruto % | 14.6% | — | — | — | 16.4% |
| Margen Operativo % | -39.9% | — | — | — | 7.9% |
| Beneficio neto | $-3M | $-2M | $-3M | $-356.0K | $751.6K |
| EPS Diluido | — | $-0.09 | $-0.17 | — | — |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 10.5 | — | — | — | 3.1 |
| Ratio Rápido | 5.7 | — | — | — | 0.9 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-2M | — | — | — | $6.0K |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 3 declarantes · $31 total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 2 | 1 | 0 | 1 | — |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado. Cambio vs trimestre anterior no mostrado: la cobertura de los presentadores difiere demasiado entre estos dos trimestres para una comparación fiable.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| HRT FINANCIAL LP | $27 | 14 283 | 87,10% | Acciones |
| UBS Group AG | $2 | 1 | 6,45% | Acciones |
| Caitong International Asset Management Co., Ltd | $2 | 1 | 6,45% | Acciones |
Informantes de la empresa 5 insiders · 0 directivos · 0 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Jook Yuen Low | — | 13 de agosto de 2026 A | 17 390 | 0 | 0 | $0 |
| Lee Su-Leng Tan | — | 13 de agosto de 2026 A | 338 709 | 0 | 0 | $0 |
| Abdul Hamid Muhammad Azrul Bin | — | 13 de agosto de 2026 A | 32 258 | 0 | 0 | $0 |
| Set Fui Chong | — | 13 de agosto de 2026 A | 96 774 | 0 | 0 | $0 |
| Chee Keong Yap | — | 13 de agosto de 2026 A | 32 258 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 2 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Tan Lee Su-Leng | 14 de agosto de 2026 | 11,50% | Presentación inicial | Inversión pasiva | SEC |
| Soo Kow Lai, Chan Chong Wong, Liong Tai Tan, Too Kam Tham, Kim Hai Wong | 17 de enero de 2024 | — | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.